nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—AKR1C3—stomach cancer	0.157	0.426	CbGaD
Indomethacin—CXCL8—stomach cancer	0.0946	0.256	CbGaD
Indomethacin—PPARG—stomach cancer	0.0654	0.177	CbGaD
Indomethacin—CES1—Capecitabine—stomach cancer	0.0427	0.103	CbGbCtD
Indomethacin—ABCC11—Methotrexate—stomach cancer	0.0336	0.0811	CbGbCtD
Indomethacin—PTGS2—stomach cancer	0.0276	0.0747	CbGaD
Indomethacin—AKR1C3—Doxorubicin—stomach cancer	0.0265	0.064	CbGbCtD
Indomethacin—CES1—Irinotecan—stomach cancer	0.0264	0.0637	CbGbCtD
Indomethacin—ALB—stomach cancer	0.0246	0.0665	CbGaD
Indomethacin—ABCC6—Doxorubicin—stomach cancer	0.0199	0.0481	CbGbCtD
Indomethacin—ABCC3—Fluorouracil—stomach cancer	0.0168	0.0406	CbGbCtD
Indomethacin—UGT1A9—Irinotecan—stomach cancer	0.016	0.0386	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—stomach cancer	0.0156	0.0376	CbGbCtD
Indomethacin—SLC22A7—Fluorouracil—stomach cancer	0.0131	0.0317	CbGbCtD
Indomethacin—UGT1A1—Irinotecan—stomach cancer	0.0131	0.0316	CbGbCtD
Indomethacin—ABCC4—Fluorouracil—stomach cancer	0.0128	0.031	CbGbCtD
Indomethacin—ABCC1—Epirubicin—stomach cancer	0.0111	0.0267	CbGbCtD
Indomethacin—ABCC1—Irinotecan—stomach cancer	0.0108	0.026	CbGbCtD
Indomethacin—ABCB1—Mitomycin—stomach cancer	0.0101	0.0244	CbGbCtD
Indomethacin—SLC22A7—Docetaxel—stomach cancer	0.01	0.0242	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—stomach cancer	0.00957	0.0231	CbGbCtD
Indomethacin—ABCC3—Methotrexate—stomach cancer	0.00927	0.0224	CbGbCtD
Indomethacin—SLCO1B1—Irinotecan—stomach cancer	0.00906	0.0219	CbGbCtD
Indomethacin—ABCC2—Irinotecan—stomach cancer	0.00796	0.0192	CbGbCtD
Indomethacin—ABCC1—Docetaxel—stomach cancer	0.00788	0.019	CbGbCtD
Indomethacin—SLC22A11—Methotrexate—stomach cancer	0.00761	0.0184	CbGbCtD
Indomethacin—SLC22A7—Methotrexate—stomach cancer	0.00725	0.0175	CbGbCtD
Indomethacin—ABCC4—Methotrexate—stomach cancer	0.00708	0.0171	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—stomach cancer	0.00588	0.0142	CbGbCtD
Indomethacin—ABCC2—Docetaxel—stomach cancer	0.00583	0.0141	CbGbCtD
Indomethacin—ABCC1—Methotrexate—stomach cancer	0.00569	0.0137	CbGbCtD
Indomethacin—SLCO1A2—Methotrexate—stomach cancer	0.00508	0.0123	CbGbCtD
Indomethacin—ALB—Irinotecan—stomach cancer	0.00496	0.012	CbGbCtD
Indomethacin—SLCO1B1—Methotrexate—stomach cancer	0.0048	0.0116	CbGbCtD
Indomethacin—ALB—Fluorouracil—stomach cancer	0.00476	0.0115	CbGbCtD
Indomethacin—SLC22A8—Methotrexate—stomach cancer	0.00443	0.0107	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—stomach cancer	0.00435	0.0105	CbGbCtD
Indomethacin—CYP2C9—Capecitabine—stomach cancer	0.00433	0.0105	CbGbCtD
Indomethacin—ABCC2—Methotrexate—stomach cancer	0.00421	0.0102	CbGbCtD
Indomethacin—SLC10A1—bile—stomach cancer	0.00361	0.069	CbGeAlD
Indomethacin—SLC22A6—Methotrexate—stomach cancer	0.00308	0.00745	CbGbCtD
Indomethacin—ALB—Methotrexate—stomach cancer	0.00263	0.00634	CbGbCtD
Indomethacin—ABCB1—Irinotecan—stomach cancer	0.0026	0.00627	CbGbCtD
Indomethacin—CYP2C9—Fluorouracil—stomach cancer	0.00257	0.0062	CbGbCtD
Indomethacin—ABCB1—Docetaxel—stomach cancer	0.0019	0.00459	CbGbCtD
Indomethacin—ABCC2—bile—stomach cancer	0.00181	0.0347	CbGeAlD
Indomethacin—PTGDR2—hematopoietic system—stomach cancer	0.00165	0.0317	CbGeAlD
Indomethacin—ABCB1—Doxorubicin—stomach cancer	0.00142	0.00342	CbGbCtD
Indomethacin—ABCB1—Methotrexate—stomach cancer	0.00137	0.00332	CbGbCtD
Indomethacin—PPARG—Topotecan—Irinotecan—stomach cancer	0.00136	1	CbGdCrCtD
Indomethacin—PPARA—blood vessel—stomach cancer	0.00111	0.0212	CbGeAlD
Indomethacin—CES1—gall bladder—stomach cancer	0.000772	0.0148	CbGeAlD
Indomethacin—GLO1—hematopoietic system—stomach cancer	0.000678	0.013	CbGeAlD
Indomethacin—Naproxen—AKR1C3—stomach cancer	0.000659	0.316	CrCbGaD
Indomethacin—PTGR2—endocrine gland—stomach cancer	0.000631	0.0121	CbGeAlD
Indomethacin—PLA2G2A—hematopoietic system—stomach cancer	0.000631	0.0121	CbGeAlD
Indomethacin—ABCC3—gall bladder—stomach cancer	0.00063	0.0121	CbGeAlD
Indomethacin—ABCC11—endocrine gland—stomach cancer	0.000625	0.012	CbGeAlD
Indomethacin—ABCC6—hematopoietic system—stomach cancer	0.000624	0.012	CbGeAlD
Indomethacin—GLO1—epithelium—stomach cancer	0.00062	0.0119	CbGeAlD
Indomethacin—PPARG—blood vessel—stomach cancer	0.000608	0.0116	CbGeAlD
Indomethacin—GLO1—smooth muscle tissue—stomach cancer	0.000597	0.0114	CbGeAlD
Indomethacin—PPARA—hematopoietic system—stomach cancer	0.000589	0.0113	CbGeAlD
Indomethacin—PLA2G2A—epithelium—stomach cancer	0.000576	0.011	CbGeAlD
Indomethacin—PTGR2—liver—stomach cancer	0.000569	0.0109	CbGeAlD
Indomethacin—ABCC11—liver—stomach cancer	0.000563	0.0108	CbGeAlD
Indomethacin—PLA2G2A—smooth muscle tissue—stomach cancer	0.000555	0.0106	CbGeAlD
Indomethacin—GLO1—pancreas—stomach cancer	0.000552	0.0106	CbGeAlD
Indomethacin—CXCL8—smooth muscle tissue—stomach cancer	0.00055	0.0105	CbGeAlD
Indomethacin—PPARA—epithelium—stomach cancer	0.000538	0.0103	CbGeAlD
Indomethacin—ALB—gall bladder—stomach cancer	0.000537	0.0103	CbGeAlD
Indomethacin—Tolmetin—CXCL8—stomach cancer	0.000526	0.252	CrCbGaD
Indomethacin—PPARA—smooth muscle tissue—stomach cancer	0.000519	0.00993	CbGeAlD
Indomethacin—PLA2G2A—pancreas—stomach cancer	0.000513	0.00983	CbGeAlD
Indomethacin—CXCL8—pancreas—stomach cancer	0.000508	0.00973	CbGeAlD
Indomethacin—PPARA—pancreas—stomach cancer	0.00048	0.00918	CbGeAlD
Indomethacin—GLO1—lymphoid tissue—stomach cancer	0.000478	0.00914	CbGeAlD
Indomethacin—GLO1—digestive system—stomach cancer	0.000472	0.00903	CbGeAlD
Indomethacin—UGT1A9—digestive system—stomach cancer	0.000458	0.00877	CbGeAlD
Indomethacin—UGT1A1—hematopoietic system—stomach cancer	0.000451	0.00864	CbGeAlD
Indomethacin—PLA2G2A—lymphoid tissue—stomach cancer	0.000444	0.0085	CbGeAlD
Indomethacin—PLA2G2A—digestive system—stomach cancer	0.000439	0.0084	CbGeAlD
Indomethacin—CES1—hematopoietic system—stomach cancer	0.000437	0.00837	CbGeAlD
Indomethacin—PTGR2—lymph node—stomach cancer	0.000436	0.00835	CbGeAlD
Indomethacin—GLO1—bone marrow—stomach cancer	0.000435	0.00833	CbGeAlD
Indomethacin—AKR1C3—smooth muscle tissue—stomach cancer	0.000431	0.00825	CbGeAlD
Indomethacin—PPARA—lymphoid tissue—stomach cancer	0.000415	0.00794	CbGeAlD
Indomethacin—PPARA—digestive system—stomach cancer	0.00041	0.00784	CbGeAlD
Indomethacin—CXCL8—bone marrow—stomach cancer	0.0004	0.00766	CbGeAlD
Indomethacin—AKR1C3—pancreas—stomach cancer	0.000398	0.00763	CbGeAlD
Indomethacin—SLC10A1—digestive system—stomach cancer	0.000394	0.00754	CbGeAlD
Indomethacin—GLO1—endocrine gland—stomach cancer	0.00039	0.00746	CbGeAlD
Indomethacin—UGT1A9—endocrine gland—stomach cancer	0.000378	0.00724	CbGeAlD
Indomethacin—SLCO1B1—hematopoietic system—stomach cancer	0.000376	0.00719	CbGeAlD
Indomethacin—UGT2B7—digestive system—stomach cancer	0.000369	0.00707	CbGeAlD
Indomethacin—PLA2G2A—endocrine gland—stomach cancer	0.000362	0.00694	CbGeAlD
Indomethacin—SLC22A11—digestive system—stomach cancer	0.00036	0.00689	CbGeAlD
Indomethacin—ABCC6—endocrine gland—stomach cancer	0.000359	0.00687	CbGeAlD
Indomethacin—ABCC3—hematopoietic system—stomach cancer	0.000356	0.00682	CbGeAlD
Indomethacin—GLO1—liver—stomach cancer	0.000351	0.00673	CbGeAlD
Indomethacin—SLC22A7—digestive system—stomach cancer	0.000351	0.00672	CbGeAlD
Indomethacin—UGT1A9—liver—stomach cancer	0.000341	0.00653	CbGeAlD
Indomethacin—PPARA—endocrine gland—stomach cancer	0.000338	0.00648	CbGeAlD
Indomethacin—PLA2G2A—liver—stomach cancer	0.000327	0.00626	CbGeAlD
Indomethacin—SLC10A1—endocrine gland—stomach cancer	0.000325	0.00623	CbGeAlD
Indomethacin—PTGS1—blood vessel—stomach cancer	0.000325	0.00623	CbGeAlD
Indomethacin—PPARG—hematopoietic system—stomach cancer	0.000324	0.0062	CbGeAlD
Indomethacin—CXCL8—liver—stomach cancer	0.000323	0.00619	CbGeAlD
Indomethacin—ABCC6—liver—stomach cancer	0.000323	0.00619	CbGeAlD
Indomethacin—UGT1A1—digestive system—stomach cancer	0.000314	0.00601	CbGeAlD
Indomethacin—AKR1C3—bone marrow—stomach cancer	0.000314	0.00601	CbGeAlD
Indomethacin—PTGS2—blood vessel—stomach cancer	0.000311	0.00595	CbGeAlD
Indomethacin—CES1—lymphoid tissue—stomach cancer	0.000308	0.00589	CbGeAlD
Indomethacin—SLCO1A2—hematopoietic system—stomach cancer	0.000306	0.00585	CbGeAlD
Indomethacin—PPARA—liver—stomach cancer	0.000305	0.00584	CbGeAlD
Indomethacin—UGT2B7—endocrine gland—stomach cancer	0.000305	0.00584	CbGeAlD
Indomethacin—CES1—digestive system—stomach cancer	0.000304	0.00582	CbGeAlD
Indomethacin—Bezafibrate—PPARG—stomach cancer	0.000299	0.143	CrCbGaD
Indomethacin—SLC22A11—endocrine gland—stomach cancer	0.000297	0.00569	CbGeAlD
Indomethacin—PPARG—epithelium—stomach cancer	0.000296	0.00567	CbGeAlD
Indomethacin—ABCC4—hematopoietic system—stomach cancer	0.000294	0.00563	CbGeAlD
Indomethacin—SLC10A1—liver—stomach cancer	0.000293	0.00562	CbGeAlD
Indomethacin—PTGS2—gall bladder—stomach cancer	0.000292	0.0056	CbGeAlD
Indomethacin—SLC22A8—hematopoietic system—stomach cancer	0.000292	0.00559	CbGeAlD
Indomethacin—SLC22A7—endocrine gland—stomach cancer	0.00029	0.00555	CbGeAlD
Indomethacin—PPARG—smooth muscle tissue—stomach cancer	0.000285	0.00546	CbGeAlD
Indomethacin—UGT2B7—liver—stomach cancer	0.000275	0.00526	CbGeAlD
Indomethacin—GLO1—lymph node—stomach cancer	0.000269	0.00516	CbGeAlD
Indomethacin—SLC22A11—liver—stomach cancer	0.000268	0.00513	CbGeAlD
Indomethacin—PPARG—pancreas—stomach cancer	0.000264	0.00505	CbGeAlD
Indomethacin—SLC22A7—liver—stomach cancer	0.000262	0.00501	CbGeAlD
Indomethacin—SLCO1B1—digestive system—stomach cancer	0.000261	0.005	CbGeAlD
Indomethacin—UGT1A1—endocrine gland—stomach cancer	0.000259	0.00497	CbGeAlD
Indomethacin—AKR1C3—liver—stomach cancer	0.000254	0.00485	CbGeAlD
Indomethacin—CES1—endocrine gland—stomach cancer	0.000251	0.00481	CbGeAlD
Indomethacin—PLA2G2A—lymph node—stomach cancer	0.00025	0.0048	CbGeAlD
Indomethacin—CXCL8—lymph node—stomach cancer	0.000248	0.00475	CbGeAlD
Indomethacin—ABCC3—digestive system—stomach cancer	0.000248	0.00474	CbGeAlD
Indomethacin—CYP2C19—hematopoietic system—stomach cancer	0.000245	0.00468	CbGeAlD
Indomethacin—ABCC4—pancreas—stomach cancer	0.000239	0.00459	CbGeAlD
Indomethacin—PPARA—lymph node—stomach cancer	0.000234	0.00448	CbGeAlD
Indomethacin—UGT1A1—liver—stomach cancer	0.000234	0.00448	CbGeAlD
Indomethacin—Bromfenac—PTGS2—stomach cancer	0.000228	0.11	CrCbGaD
Indomethacin—PPARG—lymphoid tissue—stomach cancer	0.000228	0.00437	CbGeAlD
Indomethacin—CES1—liver—stomach cancer	0.000226	0.00434	CbGeAlD
Indomethacin—PPARG—digestive system—stomach cancer	0.000225	0.00431	CbGeAlD
Indomethacin—SLCO1B1—endocrine gland—stomach cancer	0.000216	0.00413	CbGeAlD
Indomethacin—SLCO1A2—digestive system—stomach cancer	0.000213	0.00407	CbGeAlD
Indomethacin—PPARG—bone marrow—stomach cancer	0.000208	0.00398	CbGeAlD
Indomethacin—ABCC3—endocrine gland—stomach cancer	0.000205	0.00392	CbGeAlD
Indomethacin—ABCC4—digestive system—stomach cancer	0.000205	0.00392	CbGeAlD
Indomethacin—ABCC2—digestive system—stomach cancer	0.000198	0.00379	CbGeAlD
Indomethacin—SLCO1B1—liver—stomach cancer	0.000195	0.00373	CbGeAlD
Indomethacin—AKR1C3—lymph node—stomach cancer	0.000194	0.00372	CbGeAlD
Indomethacin—ABCB1—blood vessel—stomach cancer	0.000192	0.00368	CbGeAlD
Indomethacin—CYP2C9—hematopoietic system—stomach cancer	0.00019	0.00363	CbGeAlD
Indomethacin—ABCC4—bone marrow—stomach cancer	0.000189	0.00361	CbGeAlD
Indomethacin—PPARG—endocrine gland—stomach cancer	0.000186	0.00356	CbGeAlD
Indomethacin—ABCC3—liver—stomach cancer	0.000185	0.00353	CbGeAlD
Indomethacin—SLCO1A2—endocrine gland—stomach cancer	0.000176	0.00336	CbGeAlD
Indomethacin—CES1—lymph node—stomach cancer	0.000174	0.00332	CbGeAlD
Indomethacin—PTGS1—hematopoietic system—stomach cancer	0.000173	0.00332	CbGeAlD
Indomethacin—CYP2C19—digestive system—stomach cancer	0.00017	0.00326	CbGeAlD
Indomethacin—ABCC4—endocrine gland—stomach cancer	0.000169	0.00324	CbGeAlD
Indomethacin—PPARG—liver—stomach cancer	0.000168	0.00321	CbGeAlD
Indomethacin—PTGS2—hematopoietic system—stomach cancer	0.000166	0.00317	CbGeAlD
Indomethacin—ABCC2—endocrine gland—stomach cancer	0.000164	0.00313	CbGeAlD
Indomethacin—SLCO1A2—liver—stomach cancer	0.000158	0.00303	CbGeAlD
Indomethacin—PTGS1—epithelium—stomach cancer	0.000158	0.00303	CbGeAlD
Indomethacin—ALB—liver—stomach cancer	0.000157	0.00301	CbGeAlD
Indomethacin—Tolmetin—PTGS2—stomach cancer	0.000154	0.0736	CrCbGaD
Indomethacin—PTGS1—smooth muscle tissue—stomach cancer	0.000153	0.00292	CbGeAlD
Indomethacin—ABCC4—liver—stomach cancer	0.000152	0.00292	CbGeAlD
Indomethacin—PTGS2—epithelium—stomach cancer	0.000151	0.0029	CbGeAlD
Indomethacin—ABCC2—liver—stomach cancer	0.000148	0.00282	CbGeAlD
Indomethacin—PTGS2—smooth muscle tissue—stomach cancer	0.000146	0.00279	CbGeAlD
Indomethacin—ABCC3—lymph node—stomach cancer	0.000142	0.00271	CbGeAlD
Indomethacin—CYP2C19—endocrine gland—stomach cancer	0.000141	0.00269	CbGeAlD
Indomethacin—PTGS2—pancreas—stomach cancer	0.000135	0.00258	CbGeAlD
Indomethacin—CYP2C9—digestive system—stomach cancer	0.000132	0.00253	CbGeAlD
Indomethacin—ABCC1—liver—stomach cancer	0.00013	0.00249	CbGeAlD
Indomethacin—PPARG—lymph node—stomach cancer	0.000129	0.00246	CbGeAlD
Indomethacin—CYP2C19—liver—stomach cancer	0.000127	0.00243	CbGeAlD
Indomethacin—ALB—lymph node—stomach cancer	0.000121	0.00231	CbGeAlD
Indomethacin—PTGS1—digestive system—stomach cancer	0.00012	0.00231	CbGeAlD
Indomethacin—ABCC4—lymph node—stomach cancer	0.000117	0.00224	CbGeAlD
Indomethacin—PTGS2—lymphoid tissue—stomach cancer	0.000117	0.00223	CbGeAlD
Indomethacin—Naproxen—PTGS2—stomach cancer	0.000115	0.0554	CrCbGaD
Indomethacin—PTGS2—digestive system—stomach cancer	0.000115	0.0022	CbGeAlD
Indomethacin—ABCC2—lymph node—stomach cancer	0.000113	0.00217	CbGeAlD
Indomethacin—CYP2C9—endocrine gland—stomach cancer	0.000109	0.00209	CbGeAlD
Indomethacin—PTGS2—bone marrow—stomach cancer	0.000106	0.00203	CbGeAlD
Indomethacin—Naproxen—ALB—stomach cancer	0.000103	0.0494	CrCbGaD
Indomethacin—ABCB1—hematopoietic system—stomach cancer	0.000102	0.00196	CbGeAlD
Indomethacin—ABCC1—lymph node—stomach cancer	9.96e-05	0.00191	CbGeAlD
Indomethacin—PTGS1—endocrine gland—stomach cancer	9.95e-05	0.00191	CbGeAlD
Indomethacin—CYP2C9—liver—stomach cancer	9.83e-05	0.00188	CbGeAlD
Indomethacin—PTGS2—endocrine gland—stomach cancer	9.51e-05	0.00182	CbGeAlD
Indomethacin—ABCB1—epithelium—stomach cancer	9.36e-05	0.00179	CbGeAlD
Indomethacin—PTGS2—liver—stomach cancer	8.57e-05	0.00164	CbGeAlD
Indomethacin—ABCB1—pancreas—stomach cancer	8.34e-05	0.0016	CbGeAlD
Indomethacin—ABCB1—lymphoid tissue—stomach cancer	7.21e-05	0.00138	CbGeAlD
Indomethacin—ABCB1—digestive system—stomach cancer	7.12e-05	0.00136	CbGeAlD
Indomethacin—PTGS1—lymph node—stomach cancer	6.88e-05	0.00132	CbGeAlD
Indomethacin—PTGS2—lymph node—stomach cancer	6.57e-05	0.00126	CbGeAlD
Indomethacin—ABCB1—bone marrow—stomach cancer	6.56e-05	0.00126	CbGeAlD
Indomethacin—ABCB1—endocrine gland—stomach cancer	5.88e-05	0.00113	CbGeAlD
Indomethacin—Discomfort—Capecitabine—stomach cancer	5.62e-05	0.000665	CcSEcCtD
Indomethacin—Epistaxis—Epirubicin—stomach cancer	5.62e-05	0.000665	CcSEcCtD
Indomethacin—Hyperglycaemia—Doxorubicin—stomach cancer	5.58e-05	0.00066	CcSEcCtD
Indomethacin—Diarrhoea—Irinotecan—stomach cancer	5.58e-05	0.000659	CcSEcCtD
Indomethacin—Agranulocytosis—Epirubicin—stomach cancer	5.56e-05	0.000658	CcSEcCtD
Indomethacin—Shock—Docetaxel—stomach cancer	5.54e-05	0.000656	CcSEcCtD
Indomethacin—Pruritus—Fluorouracil—stomach cancer	5.52e-05	0.000653	CcSEcCtD
Indomethacin—Thrombocytopenia—Docetaxel—stomach cancer	5.52e-05	0.000652	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—stomach cancer	5.51e-05	0.000652	CcSEcCtD
Indomethacin—Confusional state—Capecitabine—stomach cancer	5.5e-05	0.00065	CcSEcCtD
Indomethacin—Tachycardia—Docetaxel—stomach cancer	5.5e-05	0.00065	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	5.47e-05	0.000646	CcSEcCtD
Indomethacin—Oedema—Capecitabine—stomach cancer	5.46e-05	0.000645	CcSEcCtD
Indomethacin—Bradycardia—Epirubicin—stomach cancer	5.45e-05	0.000644	CcSEcCtD
Indomethacin—Renal failure—Doxorubicin—stomach cancer	5.42e-05	0.000641	CcSEcCtD
Indomethacin—Erythema multiforme—Methotrexate—stomach cancer	5.4e-05	0.000639	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—stomach cancer	5.4e-05	0.000639	CcSEcCtD
Indomethacin—Dizziness—Irinotecan—stomach cancer	5.39e-05	0.000637	CcSEcCtD
Indomethacin—Haemoglobin—Epirubicin—stomach cancer	5.38e-05	0.000636	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—stomach cancer	5.37e-05	0.000636	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—stomach cancer	5.37e-05	0.000636	CcSEcCtD
Indomethacin—Anorexia—Docetaxel—stomach cancer	5.37e-05	0.000635	CcSEcCtD
Indomethacin—Shock—Capecitabine—stomach cancer	5.37e-05	0.000635	CcSEcCtD
Indomethacin—Hepatitis—Epirubicin—stomach cancer	5.35e-05	0.000633	CcSEcCtD
Indomethacin—Haemorrhage—Epirubicin—stomach cancer	5.35e-05	0.000633	CcSEcCtD
Indomethacin—Diarrhoea—Fluorouracil—stomach cancer	5.34e-05	0.000632	CcSEcCtD
Indomethacin—Thrombocytopenia—Capecitabine—stomach cancer	5.34e-05	0.000632	CcSEcCtD
Indomethacin—Tinnitus—Methotrexate—stomach cancer	5.33e-05	0.00063	CcSEcCtD
Indomethacin—Tachycardia—Capecitabine—stomach cancer	5.32e-05	0.00063	CcSEcCtD
Indomethacin—ABCB1—liver—stomach cancer	5.3e-05	0.00102	CbGeAlD
Indomethacin—Sweating—Doxorubicin—stomach cancer	5.29e-05	0.000625	CcSEcCtD
Indomethacin—Hyperhidrosis—Capecitabine—stomach cancer	5.27e-05	0.000624	CcSEcCtD
Indomethacin—Hypotension—Docetaxel—stomach cancer	5.27e-05	0.000623	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—stomach cancer	5.26e-05	0.000622	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—stomach cancer	5.2e-05	0.000615	CcSEcCtD
Indomethacin—Anorexia—Capecitabine—stomach cancer	5.2e-05	0.000615	CcSEcCtD
Indomethacin—Vomiting—Irinotecan—stomach cancer	5.18e-05	0.000613	CcSEcCtD
Indomethacin—Dizziness—Fluorouracil—stomach cancer	5.16e-05	0.00061	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—stomach cancer	5.15e-05	0.000608	CcSEcCtD
Indomethacin—Rash—Irinotecan—stomach cancer	5.14e-05	0.000608	CcSEcCtD
Indomethacin—Dermatitis—Irinotecan—stomach cancer	5.13e-05	0.000607	CcSEcCtD
Indomethacin—Headache—Irinotecan—stomach cancer	5.11e-05	0.000604	CcSEcCtD
Indomethacin—Hypotension—Capecitabine—stomach cancer	5.1e-05	0.000603	CcSEcCtD
Indomethacin—Insomnia—Docetaxel—stomach cancer	5.1e-05	0.000603	CcSEcCtD
Indomethacin—Paraesthesia—Docetaxel—stomach cancer	5.06e-05	0.000598	CcSEcCtD
Indomethacin—Erythema multiforme—Epirubicin—stomach cancer	5.06e-05	0.000598	CcSEcCtD
Indomethacin—Alopecia—Methotrexate—stomach cancer	5.05e-05	0.000597	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—stomach cancer	5.04e-05	0.000596	CcSEcCtD
Indomethacin—Dyspnoea—Docetaxel—stomach cancer	5.02e-05	0.000594	CcSEcCtD
Indomethacin—Somnolence—Docetaxel—stomach cancer	5.01e-05	0.000592	CcSEcCtD
Indomethacin—Tinnitus—Epirubicin—stomach cancer	4.99e-05	0.00059	CcSEcCtD
Indomethacin—Erythema—Methotrexate—stomach cancer	4.98e-05	0.000588	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—stomach cancer	4.97e-05	0.000588	CcSEcCtD
Indomethacin—Flushing—Epirubicin—stomach cancer	4.96e-05	0.000587	CcSEcCtD
Indomethacin—Vomiting—Fluorouracil—stomach cancer	4.96e-05	0.000587	CcSEcCtD
Indomethacin—Dyspepsia—Docetaxel—stomach cancer	4.96e-05	0.000587	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—stomach cancer	4.95e-05	0.000585	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—stomach cancer	4.95e-05	0.000585	CcSEcCtD
Indomethacin—Insomnia—Capecitabine—stomach cancer	4.93e-05	0.000583	CcSEcCtD
Indomethacin—Rash—Fluorouracil—stomach cancer	4.92e-05	0.000582	CcSEcCtD
Indomethacin—Dermatitis—Fluorouracil—stomach cancer	4.92e-05	0.000582	CcSEcCtD
Indomethacin—Paraesthesia—Capecitabine—stomach cancer	4.9e-05	0.000579	CcSEcCtD
Indomethacin—Decreased appetite—Docetaxel—stomach cancer	4.9e-05	0.000579	CcSEcCtD
Indomethacin—Headache—Fluorouracil—stomach cancer	4.89e-05	0.000578	CcSEcCtD
Indomethacin—Dyspnoea—Capecitabine—stomach cancer	4.86e-05	0.000575	CcSEcCtD
Indomethacin—Fatigue—Docetaxel—stomach cancer	4.86e-05	0.000574	CcSEcCtD
Indomethacin—Nausea—Irinotecan—stomach cancer	4.84e-05	0.000573	CcSEcCtD
Indomethacin—Pain—Docetaxel—stomach cancer	4.82e-05	0.00057	CcSEcCtD
Indomethacin—Constipation—Docetaxel—stomach cancer	4.82e-05	0.00057	CcSEcCtD
Indomethacin—Dyspepsia—Capecitabine—stomach cancer	4.8e-05	0.000568	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—stomach cancer	4.78e-05	0.000565	CcSEcCtD
Indomethacin—Decreased appetite—Capecitabine—stomach cancer	4.74e-05	0.000561	CcSEcCtD
Indomethacin—Alopecia—Epirubicin—stomach cancer	4.73e-05	0.000559	CcSEcCtD
Indomethacin—Fatigue—Capecitabine—stomach cancer	4.7e-05	0.000556	CcSEcCtD
Indomethacin—Vision blurred—Methotrexate—stomach cancer	4.69e-05	0.000555	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—stomach cancer	4.68e-05	0.000553	CcSEcCtD
Indomethacin—Pain—Capecitabine—stomach cancer	4.67e-05	0.000552	CcSEcCtD
Indomethacin—Constipation—Capecitabine—stomach cancer	4.67e-05	0.000552	CcSEcCtD
Indomethacin—Erythema—Epirubicin—stomach cancer	4.66e-05	0.000551	CcSEcCtD
Indomethacin—Feeling abnormal—Docetaxel—stomach cancer	4.64e-05	0.000549	CcSEcCtD
Indomethacin—Nausea—Fluorouracil—stomach cancer	4.64e-05	0.000548	CcSEcCtD
Indomethacin—Ill-defined disorder—Methotrexate—stomach cancer	4.62e-05	0.000546	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—stomach cancer	4.62e-05	0.000546	CcSEcCtD
Indomethacin—Gastrointestinal pain—Docetaxel—stomach cancer	4.61e-05	0.000545	CcSEcCtD
Indomethacin—Anaemia—Methotrexate—stomach cancer	4.6e-05	0.000544	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—stomach cancer	4.59e-05	0.000543	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—stomach cancer	4.59e-05	0.000543	CcSEcCtD
Indomethacin—Tension—Epirubicin—stomach cancer	4.57e-05	0.00054	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—stomach cancer	4.52e-05	0.000535	CcSEcCtD
Indomethacin—Feeling abnormal—Capecitabine—stomach cancer	4.5e-05	0.000532	CcSEcCtD
Indomethacin—Malaise—Methotrexate—stomach cancer	4.49e-05	0.000531	CcSEcCtD
Indomethacin—Vertigo—Methotrexate—stomach cancer	4.47e-05	0.000529	CcSEcCtD
Indomethacin—Gastrointestinal pain—Capecitabine—stomach cancer	4.46e-05	0.000528	CcSEcCtD
Indomethacin—Abdominal pain—Docetaxel—stomach cancer	4.45e-05	0.000527	CcSEcCtD
Indomethacin—Body temperature increased—Docetaxel—stomach cancer	4.45e-05	0.000527	CcSEcCtD
Indomethacin—Leukopenia—Methotrexate—stomach cancer	4.45e-05	0.000527	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—stomach cancer	4.42e-05	0.000523	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—stomach cancer	4.39e-05	0.000519	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—stomach cancer	4.37e-05	0.000517	CcSEcCtD
Indomethacin—Urticaria—Capecitabine—stomach cancer	4.33e-05	0.000512	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—stomach cancer	4.32e-05	0.000511	CcSEcCtD
Indomethacin—Body temperature increased—Capecitabine—stomach cancer	4.31e-05	0.00051	CcSEcCtD
Indomethacin—Abdominal pain—Capecitabine—stomach cancer	4.31e-05	0.00051	CcSEcCtD
Indomethacin—Convulsion—Methotrexate—stomach cancer	4.31e-05	0.00051	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—stomach cancer	4.31e-05	0.00051	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—stomach cancer	4.3e-05	0.000509	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—stomach cancer	4.25e-05	0.000502	CcSEcCtD
Indomethacin—Chest pain—Methotrexate—stomach cancer	4.24e-05	0.000501	CcSEcCtD
Indomethacin—Tension—Doxorubicin—stomach cancer	4.23e-05	0.0005	CcSEcCtD
Indomethacin—Malaise—Epirubicin—stomach cancer	4.2e-05	0.000497	CcSEcCtD
Indomethacin—Discomfort—Methotrexate—stomach cancer	4.19e-05	0.000495	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—stomach cancer	4.19e-05	0.000495	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—stomach cancer	4.18e-05	0.000495	CcSEcCtD
Indomethacin—Syncope—Epirubicin—stomach cancer	4.18e-05	0.000494	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—stomach cancer	4.17e-05	0.000493	CcSEcCtD
Indomethacin—Hypersensitivity—Docetaxel—stomach cancer	4.15e-05	0.000491	CcSEcCtD
Indomethacin—Palpitations—Epirubicin—stomach cancer	4.12e-05	0.000487	CcSEcCtD
Indomethacin—Confusional state—Methotrexate—stomach cancer	4.09e-05	0.000484	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—stomach cancer	4.09e-05	0.000484	CcSEcCtD
Indomethacin—ABCB1—lymph node—stomach cancer	4.07e-05	0.000779	CbGeAlD
Indomethacin—Anaphylactic shock—Methotrexate—stomach cancer	4.06e-05	0.00048	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—stomach cancer	4.06e-05	0.00048	CcSEcCtD
Indomethacin—Asthenia—Docetaxel—stomach cancer	4.04e-05	0.000478	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—stomach cancer	4.03e-05	0.000477	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—stomach cancer	4.02e-05	0.000475	CcSEcCtD
Indomethacin—Hypersensitivity—Capecitabine—stomach cancer	4.02e-05	0.000475	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—stomach cancer	4e-05	0.000473	CcSEcCtD
Indomethacin—Pruritus—Docetaxel—stomach cancer	3.99e-05	0.000471	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—stomach cancer	3.98e-05	0.000471	CcSEcCtD
Indomethacin—Thrombocytopenia—Methotrexate—stomach cancer	3.98e-05	0.00047	CcSEcCtD
Indomethacin—Chest pain—Epirubicin—stomach cancer	3.96e-05	0.000469	CcSEcCtD
Indomethacin—Anxiety—Epirubicin—stomach cancer	3.95e-05	0.000467	CcSEcCtD
Indomethacin—Hyperhidrosis—Methotrexate—stomach cancer	3.93e-05	0.000464	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—stomach cancer	3.92e-05	0.000463	CcSEcCtD
Indomethacin—Asthenia—Capecitabine—stomach cancer	3.91e-05	0.000463	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—stomach cancer	3.89e-05	0.000459	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—stomach cancer	3.87e-05	0.000458	CcSEcCtD
Indomethacin—Anorexia—Methotrexate—stomach cancer	3.87e-05	0.000458	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—stomach cancer	3.86e-05	0.000457	CcSEcCtD
Indomethacin—Pruritus—Capecitabine—stomach cancer	3.86e-05	0.000456	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—stomach cancer	3.86e-05	0.000456	CcSEcCtD
Indomethacin—Diarrhoea—Docetaxel—stomach cancer	3.86e-05	0.000456	CcSEcCtD
Indomethacin—Confusional state—Epirubicin—stomach cancer	3.83e-05	0.000453	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—stomach cancer	3.81e-05	0.00045	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—stomach cancer	3.8e-05	0.000449	CcSEcCtD
Indomethacin—Oedema—Epirubicin—stomach cancer	3.8e-05	0.000449	CcSEcCtD
Indomethacin—Hypotension—Methotrexate—stomach cancer	3.79e-05	0.000449	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—stomach cancer	3.79e-05	0.000448	CcSEcCtD
Indomethacin—Shock—Epirubicin—stomach cancer	3.74e-05	0.000442	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—stomach cancer	3.73e-05	0.000441	CcSEcCtD
Indomethacin—Diarrhoea—Capecitabine—stomach cancer	3.73e-05	0.000441	CcSEcCtD
Indomethacin—Dizziness—Docetaxel—stomach cancer	3.73e-05	0.000441	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—stomach cancer	3.72e-05	0.00044	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—stomach cancer	3.72e-05	0.00044	CcSEcCtD
Indomethacin—Tachycardia—Epirubicin—stomach cancer	3.71e-05	0.000439	CcSEcCtD
Indomethacin—Hyperhidrosis—Epirubicin—stomach cancer	3.67e-05	0.000434	CcSEcCtD
Indomethacin—Insomnia—Methotrexate—stomach cancer	3.67e-05	0.000434	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—stomach cancer	3.67e-05	0.000434	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—stomach cancer	3.66e-05	0.000432	CcSEcCtD
Indomethacin—Paraesthesia—Methotrexate—stomach cancer	3.65e-05	0.000431	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—stomach cancer	3.62e-05	0.000429	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—stomach cancer	3.62e-05	0.000428	CcSEcCtD
Indomethacin—Dyspnoea—Methotrexate—stomach cancer	3.62e-05	0.000428	CcSEcCtD
Indomethacin—Somnolence—Methotrexate—stomach cancer	3.61e-05	0.000427	CcSEcCtD
Indomethacin—Dizziness—Capecitabine—stomach cancer	3.61e-05	0.000427	CcSEcCtD
Indomethacin—Vomiting—Docetaxel—stomach cancer	3.58e-05	0.000424	CcSEcCtD
Indomethacin—Dyspepsia—Methotrexate—stomach cancer	3.57e-05	0.000423	CcSEcCtD
Indomethacin—Rash—Docetaxel—stomach cancer	3.55e-05	0.00042	CcSEcCtD
Indomethacin—Hypotension—Epirubicin—stomach cancer	3.55e-05	0.00042	CcSEcCtD
Indomethacin—Dermatitis—Docetaxel—stomach cancer	3.55e-05	0.00042	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—stomach cancer	3.55e-05	0.000419	CcSEcCtD
Indomethacin—Decreased appetite—Methotrexate—stomach cancer	3.53e-05	0.000417	CcSEcCtD
Indomethacin—Headache—Docetaxel—stomach cancer	3.53e-05	0.000417	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—stomach cancer	3.52e-05	0.000416	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—stomach cancer	3.52e-05	0.000416	CcSEcCtD
Indomethacin—Fatigue—Methotrexate—stomach cancer	3.5e-05	0.000414	CcSEcCtD
Indomethacin—Pain—Methotrexate—stomach cancer	3.47e-05	0.000411	CcSEcCtD
Indomethacin—Vomiting—Capecitabine—stomach cancer	3.47e-05	0.00041	CcSEcCtD
Indomethacin—Shock—Doxorubicin—stomach cancer	3.46e-05	0.000409	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—stomach cancer	3.44e-05	0.000407	CcSEcCtD
Indomethacin—Rash—Capecitabine—stomach cancer	3.44e-05	0.000407	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—stomach cancer	3.44e-05	0.000406	CcSEcCtD
Indomethacin—Dermatitis—Capecitabine—stomach cancer	3.44e-05	0.000406	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—stomach cancer	3.43e-05	0.000406	CcSEcCtD
Indomethacin—Headache—Capecitabine—stomach cancer	3.42e-05	0.000404	CcSEcCtD
Indomethacin—Paraesthesia—Epirubicin—stomach cancer	3.41e-05	0.000404	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—stomach cancer	3.4e-05	0.000402	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—stomach cancer	3.39e-05	0.000401	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—stomach cancer	3.38e-05	0.0004	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—stomach cancer	3.35e-05	0.000396	CcSEcCtD
Indomethacin—Nausea—Docetaxel—stomach cancer	3.35e-05	0.000396	CcSEcCtD
Indomethacin—Feeling abnormal—Methotrexate—stomach cancer	3.35e-05	0.000396	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—stomach cancer	3.35e-05	0.000396	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methotrexate—stomach cancer	3.32e-05	0.000393	CcSEcCtD
Indomethacin—Decreased appetite—Epirubicin—stomach cancer	3.3e-05	0.000391	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—stomach cancer	3.29e-05	0.000389	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—stomach cancer	3.28e-05	0.000387	CcSEcCtD
Indomethacin—Pain—Epirubicin—stomach cancer	3.25e-05	0.000384	CcSEcCtD
Indomethacin—Constipation—Epirubicin—stomach cancer	3.25e-05	0.000384	CcSEcCtD
Indomethacin—Nausea—Capecitabine—stomach cancer	3.24e-05	0.000383	CcSEcCtD
Indomethacin—Urticaria—Methotrexate—stomach cancer	3.23e-05	0.000382	CcSEcCtD
Indomethacin—Body temperature increased—Methotrexate—stomach cancer	3.21e-05	0.00038	CcSEcCtD
Indomethacin—Abdominal pain—Methotrexate—stomach cancer	3.21e-05	0.00038	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—stomach cancer	3.18e-05	0.000376	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—stomach cancer	3.16e-05	0.000373	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—stomach cancer	3.14e-05	0.000371	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—stomach cancer	3.13e-05	0.00037	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—stomach cancer	3.13e-05	0.00037	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—stomach cancer	3.11e-05	0.000368	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—stomach cancer	3.1e-05	0.000366	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—stomach cancer	3.06e-05	0.000361	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—stomach cancer	3.03e-05	0.000359	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—stomach cancer	3.02e-05	0.000357	CcSEcCtD
Indomethacin—Pain—Doxorubicin—stomach cancer	3.01e-05	0.000356	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—stomach cancer	3.01e-05	0.000356	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—stomach cancer	3e-05	0.000355	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—stomach cancer	3e-05	0.000355	CcSEcCtD
Indomethacin—Hypersensitivity—Methotrexate—stomach cancer	2.99e-05	0.000354	CcSEcCtD
Indomethacin—Asthenia—Methotrexate—stomach cancer	2.91e-05	0.000345	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—stomach cancer	2.9e-05	0.000343	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—stomach cancer	2.88e-05	0.00034	CcSEcCtD
Indomethacin—Pruritus—Methotrexate—stomach cancer	2.87e-05	0.00034	CcSEcCtD
Indomethacin—Hypersensitivity—Epirubicin—stomach cancer	2.8e-05	0.000331	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—stomach cancer	2.79e-05	0.00033	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—stomach cancer	2.78e-05	0.000329	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—stomach cancer	2.78e-05	0.000329	CcSEcCtD
Indomethacin—Diarrhoea—Methotrexate—stomach cancer	2.78e-05	0.000329	CcSEcCtD
Indomethacin—Asthenia—Epirubicin—stomach cancer	2.73e-05	0.000322	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—stomach cancer	2.69e-05	0.000318	CcSEcCtD
Indomethacin—Dizziness—Methotrexate—stomach cancer	2.69e-05	0.000318	CcSEcCtD
Indomethacin—Diarrhoea—Epirubicin—stomach cancer	2.6e-05	0.000307	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—stomach cancer	2.59e-05	0.000306	CcSEcCtD
Indomethacin—Vomiting—Methotrexate—stomach cancer	2.58e-05	0.000305	CcSEcCtD
Indomethacin—Rash—Methotrexate—stomach cancer	2.56e-05	0.000303	CcSEcCtD
Indomethacin—Dermatitis—Methotrexate—stomach cancer	2.56e-05	0.000303	CcSEcCtD
Indomethacin—Headache—Methotrexate—stomach cancer	2.54e-05	0.000301	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—stomach cancer	2.52e-05	0.000298	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—stomach cancer	2.51e-05	0.000297	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—stomach cancer	2.49e-05	0.000294	CcSEcCtD
Indomethacin—Vomiting—Epirubicin—stomach cancer	2.42e-05	0.000286	CcSEcCtD
Indomethacin—Nausea—Methotrexate—stomach cancer	2.41e-05	0.000285	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—stomach cancer	2.41e-05	0.000285	CcSEcCtD
Indomethacin—Rash—Epirubicin—stomach cancer	2.4e-05	0.000283	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—stomach cancer	2.39e-05	0.000283	CcSEcCtD
Indomethacin—Headache—Epirubicin—stomach cancer	2.38e-05	0.000282	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—stomach cancer	2.33e-05	0.000275	CcSEcCtD
Indomethacin—Nausea—Epirubicin—stomach cancer	2.26e-05	0.000267	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—stomach cancer	2.24e-05	0.000264	CcSEcCtD
Indomethacin—Rash—Doxorubicin—stomach cancer	2.22e-05	0.000262	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—stomach cancer	2.22e-05	0.000262	CcSEcCtD
Indomethacin—Headache—Doxorubicin—stomach cancer	2.2e-05	0.000261	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—stomach cancer	2.09e-05	0.000247	CcSEcCtD
Indomethacin—UGT2B7—Metabolism—ALB—stomach cancer	2.38e-06	3.12e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ALB—stomach cancer	2.38e-06	3.12e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKR1C3—stomach cancer	2.37e-06	3.11e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—KRAS—stomach cancer	2.37e-06	3.11e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CAV1—stomach cancer	2.36e-06	3.09e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.35e-06	3.09e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—APOA1—stomach cancer	2.35e-06	3.09e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.35e-06	3.08e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.34e-06	3.07e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PIK3CA—stomach cancer	2.33e-06	3.05e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MMP9—stomach cancer	2.32e-06	3.05e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALOX5—stomach cancer	2.32e-06	3.04e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CDKN1A—stomach cancer	2.32e-06	3.04e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ENO1—stomach cancer	2.31e-06	3.03e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RHOA—stomach cancer	2.31e-06	3.03e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PPARG—stomach cancer	2.3e-06	3.02e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ERCC2—stomach cancer	2.3e-06	3.02e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NOS3—stomach cancer	2.29e-06	3e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—DPYD—stomach cancer	2.28e-06	3e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—NOS3—stomach cancer	2.28e-06	2.99e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—NOS3—stomach cancer	2.28e-06	2.99e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.27e-06	2.98e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FYN—stomach cancer	2.27e-06	2.98e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PIK3CA—stomach cancer	2.27e-06	2.97e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK8—stomach cancer	2.26e-06	2.97e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.25e-06	2.96e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ALB—stomach cancer	2.25e-06	2.95e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CAV1—stomach cancer	2.24e-06	2.94e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—APOA1—stomach cancer	2.24e-06	2.93e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SERPINE1—stomach cancer	2.23e-06	2.93e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTT1—stomach cancer	2.21e-06	2.91e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP2A6—stomach cancer	2.19e-06	2.87e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERCC2—stomach cancer	2.18e-06	2.86e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PIK3CA—stomach cancer	2.18e-06	2.86e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—MTHFR—stomach cancer	2.16e-06	2.84e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTT1—stomach cancer	2.16e-06	2.84e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPP2R1A—stomach cancer	2.15e-06	2.83e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HRAS—stomach cancer	2.15e-06	2.83e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—NOS3—stomach cancer	2.15e-06	2.82e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—RHOA—stomach cancer	2.15e-06	2.82e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PPARG—stomach cancer	2.15e-06	2.82e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PPARG—stomach cancer	2.15e-06	2.82e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.14e-06	2.81e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ERBB2—stomach cancer	2.14e-06	2.8e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP2A6—stomach cancer	2.14e-06	2.8e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOS3—stomach cancer	2.13e-06	2.79e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKR1C3—stomach cancer	2.13e-06	2.79e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGFR2—stomach cancer	2.13e-06	2.79e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSTP1—stomach cancer	2.11e-06	2.77e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—stomach cancer	2.09e-06	2.74e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—HMOX1—stomach cancer	2.08e-06	2.73e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—stomach cancer	2.08e-06	2.73e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—stomach cancer	2.08e-06	2.73e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKR1C3—stomach cancer	2.08e-06	2.73e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ENO1—stomach cancer	2.08e-06	2.72e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PPARG—stomach cancer	2.07e-06	2.72e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ALB—stomach cancer	2.07e-06	2.72e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.07e-06	2.72e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—STAT3—stomach cancer	2.07e-06	2.71e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—IL6—stomach cancer	2.06e-06	2.7e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CD44—stomach cancer	2.05e-06	2.69e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTHFR—stomach cancer	2.05e-06	2.69e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.04e-06	2.68e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ENO1—stomach cancer	2.03e-06	2.66e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTT1—stomach cancer	2.02e-06	2.65e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRAS—stomach cancer	2.01e-06	2.64e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP2A6—stomach cancer	2e-06	2.62e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CAV1—stomach cancer	1.99e-06	2.62e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ERBB2—stomach cancer	1.99e-06	2.61e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOA1—stomach cancer	1.99e-06	2.61e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.99e-06	2.61e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—NOS3—stomach cancer	1.98e-06	2.6e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1B—stomach cancer	1.98e-06	2.6e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK3—stomach cancer	1.97e-06	2.59e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PPARG—stomach cancer	1.97e-06	2.59e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—stomach cancer	1.97e-06	2.58e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TYMS—stomach cancer	1.96e-06	2.58e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IRS2—stomach cancer	1.95e-06	2.56e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PIK3CA—stomach cancer	1.95e-06	2.56e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—stomach cancer	1.95e-06	2.56e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSTM1—stomach cancer	1.94e-06	2.55e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKR1C3—stomach cancer	1.94e-06	2.55e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ALB—stomach cancer	1.93e-06	2.54e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ALB—stomach cancer	1.93e-06	2.54e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL6—stomach cancer	1.93e-06	2.53e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MYC—stomach cancer	1.92e-06	2.52e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.91e-06	2.5e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.89e-06	2.48e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ENO1—stomach cancer	1.89e-06	2.48e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CAV1—stomach cancer	1.89e-06	2.48e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCND1—stomach cancer	1.89e-06	2.48e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MAPK3—stomach cancer	1.89e-06	2.48e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOA1—stomach cancer	1.89e-06	2.47e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—JUN—stomach cancer	1.88e-06	2.47e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK1—stomach cancer	1.88e-06	2.46e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—stomach cancer	1.88e-06	2.46e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—stomach cancer	1.86e-06	2.45e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.86e-06	2.44e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—NOS3—stomach cancer	1.85e-06	2.43e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—NOS3—stomach cancer	1.85e-06	2.43e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1B—stomach cancer	1.85e-06	2.42e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CD44—stomach cancer	1.84e-06	2.41e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—stomach cancer	1.84e-06	2.41e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—stomach cancer	1.83e-06	2.41e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CDKN1A—stomach cancer	1.83e-06	2.4e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ERCC2—stomach cancer	1.83e-06	2.4e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—stomach cancer	1.81e-06	2.38e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CD44—stomach cancer	1.8e-06	2.36e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6ST—stomach cancer	1.79e-06	2.35e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.79e-06	2.34e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—NOS3—stomach cancer	1.78e-06	2.34e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK8—stomach cancer	1.78e-06	2.34e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—stomach cancer	1.77e-06	2.33e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—stomach cancer	1.77e-06	2.32e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PPARG—stomach cancer	1.75e-06	2.3e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPP2R1A—stomach cancer	1.74e-06	2.29e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APC—stomach cancer	1.72e-06	2.26e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—stomach cancer	1.72e-06	2.26e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—MTHFR—stomach cancer	1.72e-06	2.25e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTP1—stomach cancer	1.71e-06	2.24e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CDKN1A—stomach cancer	1.7e-06	2.23e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—NOS3—stomach cancer	1.7e-06	2.22e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—stomach cancer	1.69e-06	2.22e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—stomach cancer	1.69e-06	2.22e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—stomach cancer	1.69e-06	2.22e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HMOX1—stomach cancer	1.69e-06	2.21e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CD44—stomach cancer	1.68e-06	2.2e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—stomach cancer	1.65e-06	2.16e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—stomach cancer	1.63e-06	2.14e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—stomach cancer	1.63e-06	2.14e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—stomach cancer	1.63e-06	2.14e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.63e-06	2.14e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK3—stomach cancer	1.63e-06	2.14e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6R—stomach cancer	1.6e-06	2.1e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TYMS—stomach cancer	1.59e-06	2.09e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CAV1—stomach cancer	1.58e-06	2.08e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOA1—stomach cancer	1.58e-06	2.07e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—stomach cancer	1.58e-06	2.07e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—stomach cancer	1.58e-06	2.07e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTM1—stomach cancer	1.57e-06	2.06e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPP2R1A—stomach cancer	1.56e-06	2.05e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK3—stomach cancer	1.56e-06	2.04e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—stomach cancer	1.55e-06	2.03e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK1—stomach cancer	1.55e-06	2.03e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTP1—stomach cancer	1.54e-06	2.01e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.53e-06	2e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—stomach cancer	1.52e-06	1.99e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—stomach cancer	1.51e-06	1.99e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMOX1—stomach cancer	1.51e-06	1.99e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.51e-06	1.98e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—stomach cancer	1.51e-06	1.98e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NOS3—stomach cancer	1.51e-06	1.98e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTP1—stomach cancer	1.5e-06	1.97e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SERPINE1—stomach cancer	1.5e-06	1.96e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK1—stomach cancer	1.48e-06	1.94e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—stomach cancer	1.48e-06	1.94e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMOX1—stomach cancer	1.48e-06	1.94e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ERCC2—stomach cancer	1.48e-06	1.94e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—stomach cancer	1.46e-06	1.92e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK3—stomach cancer	1.45e-06	1.9e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—RHOA—stomach cancer	1.44e-06	1.89e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL6—stomach cancer	1.44e-06	1.89e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS3—stomach cancer	1.43e-06	1.88e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TYMS—stomach cancer	1.43e-06	1.87e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPP2R1A—stomach cancer	1.43e-06	1.87e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—stomach cancer	1.41e-06	1.85e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTM1—stomach cancer	1.41e-06	1.85e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—stomach cancer	1.4e-06	1.84e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTP1—stomach cancer	1.4e-06	1.84e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TYMS—stomach cancer	1.39e-06	1.83e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PPARG—stomach cancer	1.39e-06	1.83e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—MTHFR—stomach cancer	1.39e-06	1.82e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK1—stomach cancer	1.38e-06	1.81e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—stomach cancer	1.38e-06	1.81e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMOX1—stomach cancer	1.38e-06	1.81e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—stomach cancer	1.38e-06	1.81e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTM1—stomach cancer	1.38e-06	1.81e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—stomach cancer	1.34e-06	1.76e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB2—stomach cancer	1.34e-06	1.75e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ERCC2—stomach cancer	1.33e-06	1.74e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—stomach cancer	1.3e-06	1.71e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TYMS—stomach cancer	1.3e-06	1.71e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—stomach cancer	1.3e-06	1.71e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ERCC2—stomach cancer	1.29e-06	1.7e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTM1—stomach cancer	1.29e-06	1.69e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—stomach cancer	1.29e-06	1.69e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—stomach cancer	1.28e-06	1.68e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—stomach cancer	1.28e-06	1.68e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAV1—stomach cancer	1.28e-06	1.68e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOA1—stomach cancer	1.28e-06	1.68e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—stomach cancer	1.25e-06	1.64e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—MTHFR—stomach cancer	1.25e-06	1.64e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—stomach cancer	1.24e-06	1.63e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—stomach cancer	1.24e-06	1.63e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1B—stomach cancer	1.24e-06	1.62e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.22e-06	1.61e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—MTHFR—stomach cancer	1.22e-06	1.6e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—stomach cancer	1.21e-06	1.59e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ERCC2—stomach cancer	1.21e-06	1.59e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—stomach cancer	1.2e-06	1.57e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NOS3—stomach cancer	1.2e-06	1.57e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—stomach cancer	1.19e-06	1.56e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAV1—stomach cancer	1.15e-06	1.51e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOA1—stomach cancer	1.15e-06	1.51e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDKN1A—stomach cancer	1.14e-06	1.5e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6—stomach cancer	1.14e-06	1.49e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—MTHFR—stomach cancer	1.14e-06	1.49e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PPARG—stomach cancer	1.13e-06	1.48e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAV1—stomach cancer	1.12e-06	1.47e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOA1—stomach cancer	1.12e-06	1.47e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—stomach cancer	1.12e-06	1.46e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—stomach cancer	1.11e-06	1.45e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.1e-06	1.44e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6—stomach cancer	1.06e-06	1.39e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAV1—stomach cancer	1.05e-06	1.38e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOA1—stomach cancer	1.05e-06	1.37e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—stomach cancer	1.04e-06	1.37e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—stomach cancer	1.04e-06	1.37e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—stomach cancer	1.02e-06	1.34e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PPARG—stomach cancer	1.01e-06	1.33e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—stomach cancer	1e-06	1.32e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1e-06	1.31e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PPARG—stomach cancer	9.87e-07	1.29e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK3—stomach cancer	9.74e-07	1.28e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NOS3—stomach cancer	9.69e-07	1.27e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—stomach cancer	9.54e-07	1.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—stomach cancer	9.48e-07	1.24e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK1—stomach cancer	9.27e-07	1.22e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—stomach cancer	9.27e-07	1.22e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PPARG—stomach cancer	9.22e-07	1.21e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—stomach cancer	9.09e-07	1.19e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—stomach cancer	8.87e-07	1.16e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—stomach cancer	8.86e-07	1.16e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—stomach cancer	8.76e-07	1.15e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NOS3—stomach cancer	8.69e-07	1.14e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NOS3—stomach cancer	8.49e-07	1.11e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—stomach cancer	8.49e-07	1.11e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—stomach cancer	8.29e-07	1.09e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—stomach cancer	8.04e-07	1.06e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—stomach cancer	7.95e-07	1.04e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NOS3—stomach cancer	7.93e-07	1.04e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—stomach cancer	7.76e-07	1.02e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—stomach cancer	7.44e-07	9.76e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—stomach cancer	7.25e-07	9.51e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6—stomach cancer	7.12e-07	9.34e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—stomach cancer	6.74e-07	8.84e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—stomach cancer	5.45e-07	7.15e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—stomach cancer	4.89e-07	6.42e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—stomach cancer	4.78e-07	6.26e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—stomach cancer	4.46e-07	5.85e-06	CbGpPWpGaD
